BACKGROUND: In the treatment of atrial fibrillation (AF), the most frequently sustained arrhythmia, with catheter ablation (CA) or electrical cardioversion (ECV), the periprocedural period is one of the most critical phases. Currently, the use of new direct action oral anticoagulants (DOAC) is increasingly frequent; however, in the real world, there are still few data on studies on the thrombus incidence in the left atrium (TrLA) or dense spontaneous contrast (DSC) on transesophageal echocardiogram (TEE). OBJECTIVE: To evaluate the prevalence of events and association with risk factors in patients using DOACs. Primary objective: to analyze the prevalence of thrombus in the LA by TEE in patients using DOAC undergoing ECV/CA. Second, evaluate the association of comorbidities with the presence of thrombi and DSC. METHODS: Retrospective cohort, single-center study with patients followed at the Arrhythmia Outpatient Unit (InCor-HCFMUSP). Patients indicated for procedures and using DOACs were selected, and their clinical/echocardiographic data were analyzed. A significance level of 5% was considered. RESULTS: 354 patients were included, a total of 400 procedures, from March 2012-March 2018. Thrombus in the LA was found in 11 patients (2.8%), associated with advanced age (p=0.007) and higher CHA2DS2-VASc (p<0.001) score. DSC in the LA before TEE was found in 29 patients (7.3%), with lower LVEF (p<0.038) and greater LA dimension (p<0.0001). CONCLUSION: The incidence of LA thrombus and DSC in patients using DOC in the context of AF ECV/CA, although small, is not negligible. Patients with higher CHA2DS2-VASc scores, especially older and with larger LA diameter, are more prone to these echocardiographic findings.
BACKGROUND: In the treatment of atrial fibrillation (AF), the most frequently sustained arrhythmia, with catheter ablation (CA) or electrical cardioversion (ECV), the periprocedural period is one of the most critical phases. Currently, the use of new direct action oral anticoagulants (DOAC) is increasingly frequent; however, in the real world, there are still few data on studies on the thrombus incidence in the left atrium (TrLA) or dense spontaneous contrast (DSC) on transesophageal echocardiogram (TEE). OBJECTIVE: To evaluate the prevalence of events and association with risk factors in patients using DOACs. Primary objective: to analyze the prevalence of thrombus in the LA by TEE in patients using DOAC undergoing ECV/CA. Second, evaluate the association of comorbidities with the presence of thrombi and DSC. METHODS: Retrospective cohort, single-center study with patients followed at the Arrhythmia Outpatient Unit (InCor-HCFMUSP). Patients indicated for procedures and using DOACs were selected, and their clinical/echocardiographic data were analyzed. A significance level of 5% was considered. RESULTS: 354 patients were included, a total of 400 procedures, from March 2012-March 2018. Thrombus in the LA was found in 11 patients (2.8%), associated with advanced age (p=0.007) and higher CHA2DS2-VASc (p<0.001) score. DSC in the LA before TEE was found in 29 patients (7.3%), with lower LVEF (p<0.038) and greater LA dimension (p<0.0001). CONCLUSION: The incidence of LA thrombus and DSC in patients using DOC in the context of AF ECV/CA, although small, is not negligible. Patients with higher CHA2DS2-VASc scores, especially older and with larger LA diameter, are more prone to these echocardiographic findings.
Authors: Craig T January; L Samuel Wann; Joseph S Alpert; Hugh Calkins; Joaquin E Cigarroa; Joseph C Cleveland; Jamie B Conti; Patrick T Ellinor; Michael D Ezekowitz; Michael E Field; Katherine T Murray; Ralph L Sacco; William G Stevenson; Patrick J Tchou; Cynthia M Tracy; Clyde W Yancy Journal: J Am Coll Cardiol Date: 2014-03-28 Impact factor: 24.094
Authors: Yang Zhan; Jacqueline Joza; Mohamed Al Rawahi; Rodrigo S Barbosa; Michelle Samuel; Martin Bernier; Thao Huynh; George Thanassoulis; Vidal Essebag Journal: Can J Cardiol Date: 2017-12-15 Impact factor: 5.223
Authors: Greg Flaker; Renato D Lopes; Sana M Al-Khatib; Antonio G Hermosillo; Stefan H Hohnloser; Brian Tinga; Jun Zhu; Puneet Mohan; David Garcia; Jozef Bartunek; Dragos Vinereanu; Steen Husted; Veli Pekka Harjola; Marten Rosenqvist; John H Alexander; Christopher B Granger Journal: J Am Coll Cardiol Date: 2013-11-06 Impact factor: 24.094
Authors: Sarinya Puwanant; Brandon C Varr; Kevin Shrestha; Sarah K Hussain; W H Wilson Tang; Ruvin S Gabriel; Oussama M Wazni; Mandeep Bhargava; Walid I Saliba; James D Thomas; Bruce D Lindsay; Allan L Klein Journal: J Am Coll Cardiol Date: 2009-11-24 Impact factor: 24.094
Authors: Jonathan P Piccini; Susanna R Stevens; Yuliya Lokhnygina; Manesh R Patel; Jonathan L Halperin; Daniel E Singer; Graeme J Hankey; Werner Hacke; Richard C Becker; Christopher C Nessel; Kenneth W Mahaffey; Keith A A Fox; Robert M Califf; Günter Breithardt Journal: J Am Coll Cardiol Date: 2013-03-14 Impact factor: 24.094
Authors: Christoph Stellbrink; Uwe Nixdorff; Thomas Hofmann; Walter Lehmacher; Werner Günther Daniel; Peter Hanrath; Christoph Geller; Andreas Mügge; Walter Sehnert; Caroline Schmidt-Lucke; Jan-André Schmidt-Lucke Journal: Circulation Date: 2004-02-16 Impact factor: 29.690
Authors: Michael Wu; James Gabriels; Mohammad Khan; Nada Shaban; Salvatore D'Amato; Christopher F Liu; Steven M Markowitz; James E Ip; George Thomas; Parmanand Singh; Bruce Lerman; Apoor Patel; Jim W Cheung Journal: Heart Rhythm Date: 2018-04 Impact factor: 6.343
Authors: Wael Alqarawi; David H Birnie; Stewart Spence; F Daniel Ramirez; Calum J Redpath; Robert Lemery; Girish M Nair; Pablo B Nery; Darryl R Davis; Martin S Green; Luc Beauchesne; Kwan Chan; Kathryn Ascah; Ian Burwash; Mouhannad M Sadek Journal: Europace Date: 2019-01-01 Impact factor: 5.214
Authors: Mohamed Al Rawahi; Michelle Samuel; Christos Galatas; Jacqueline Joza; Pedro Y Lima; Rodrigo Barbosa; George Thanassoulis; Martin L Bernier; Thao Huynh; Vidal Essebag Journal: CJC Open Date: 2019-07-02